Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
CONTERA PHARMA A/S
A/S
Active
CVR 33062214
Venlighedsvej 4, 2970
Hørsholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2010 · 15 years old
21 employees
www.conterapharma.com
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
CONTERA PHARMA A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
6M
12M
18M
24M
-24M
2021
-45M
2022
-59M
2023
-54M
2024
21M
2025
EBITDA
DKK millions
0M
-24M
-48M
-72M
-96M
-36M
2021
-58M
-61%
2022
-77M
-33%
2023
-74M
+4%
2024
-4M
+95%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-24.154
-44.832
-58.994
-54.084
20.632
Staff expenses
-12.112
-13.226
-17.994
-19.859
-24.803
EBITDA
-36.266
-58.058
-76.988
-73.985
-4.171
Depreciation & amort.
-126
-4.026
-1.272
-1.642
-1.813
EBIT
-36.392
-62.084
-78.260
-75.626
-5.984
Net financials
-189
-285
1.439
913
-79
Profit before tax
-36.581
-62.368
-76.820
-74.714
-6.063
Tax
-5.062
-5.500
-5.500
-5.500
-1.279
Net profit
-31.519
-56.868
-71.320
-69.214
-4.784
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
167.213
115.743
92.369
63.610
97.551
Equity
163.442
106.574
86.298
54.388
79.472
Long-term debt
0
0
0
0
0
Short-term debt
3.771
9.169
6.071
9.222
18.079
Total debt
3.771
9.169
6.071
9.222
18.079
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-20.2%
This company
2021
2025
Soliditetsgrad
81.5%
This company
38.2%
Market median
+113% vs market
2021
2025
Egenkapitalforrentning
-6.0%
This company
18.4%
Market median
-133% vs market
2021
2025
Nettoresultatgrad (af bruttofortjeneste)
-23.2%
This company
2021
2025
Aktivomsætning (af bruttofortjeneste)
0.21×
This company
2021
2025
Gæld/egenkapital
0.23×
This company
0.62×
Market median
+63% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on CONTERA PHARMA A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
